Roundup Non-Hodgkin Lymphoma Product Liability After the Supreme Court’s FIFRA Preemption Ruling Overturned Plaintiff John Durnell’s $1.25M Jury Verdict — Two Decades of Glyphosate Exposure and a Blood Cancer the Jury Linked to the Manufacturer’s Herbicide, the IARC Classification as Probably Carcinogenic to Humans Versus the EPA Finding That Shielded the Agrochemical Industry, Attorney911 Pursues Bayer/Monsanto on Surviving Design-Defect and Fraudulent-Concealment Theories When Failure-to-Warn Is Preempted, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider Who Knows How the Claims Machine Values and Denies Toxic-Tort Cases, We Secure Monsanto’s Internal Corporate Documents, Exposure Records and Medical Proof Before the Spoliation Clock Runs, Missouri’s No-Damage-Cap Product Liability Doctrine and Punitive-Damages Standard for Reckless Disregard, the Firm Has Recovered $50M+ for Injury Victims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911
The Supreme Court Just Closed the Main Door on Roundup Cancer Cases — Here Is What That Actually Means for You You heard the news and your stomach dropped. The Supreme Court ruled that Bayer — the company that makes Roundup — does not have to warn consumers about a potential cancer risk. You or someone you love used Roundup for years and then got non-Hodgkin lymphoma. You may already have a lawyer. You may have been thinking about calling one. Now you are staring at your phone at 2 a.m. wondering whether the courthouse door just slammed shut. It did not slam all the way. The Supreme Court closed the biggest, most common door — the failure-to-warn claim, the theory that drove most of the verdicts and most of the settlements. But the ruling is not a blanket immunity for Bayer. It is a preemption ruling, grounded in one specific federal statute and one specific regulatory finding that is itself under a cloud. And there are other doors — fraud-based theories, design-defect theories, claims that the company manipulated the science it fed to the regulator — that may still be open. We are writing this page for one person:…